Global study tracks new lupus drug in everyday use
NCT ID NCT06314282
Summary
This study is observing how well the medication anifrolumab works for people with lupus when used in regular doctor's offices, not just in clinical trials. It will follow 200 patients across several countries for one year to see how their symptoms, skin problems, and quality of life change. The goal is to provide real-world information to help doctors and patients make better treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGAktobe, Kazakhstan
-
Research Site
RECRUITINGAlmaty, Kazakhstan
-
Research Site
RECRUITINGAstana, Kazakhstan
-
Research Site
RECRUITINGPavlodar, Kazakhstan
-
Research Site
RECRUITINGSemey, Kazakhstan
-
Research Site
RECRUITINGShymkent, Kazakhstan
Conditions
Explore the condition pages connected to this study.